Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[The accuracy of evaluating the response of metastatic lymph nodes after concurrent chemoradiotherapy in patients with head and neck squamous cell carcinoma].
Nishimura G, Komatsu M, Taguchi T, Takahashi M, Sano D, Sakuma N, Arai Y, Takahashi H, Tanaka Y, Sawakuma K, Oridate N. Nishimura G, et al. Among authors: sakuma n. Nihon Jibiinkoka Gakkai Kaiho. 2014 Jul;117(7):899-906. doi: 10.3950/jibiinkoka.117.899. Nihon Jibiinkoka Gakkai Kaiho. 2014. PMID: 25158559 Japanese.
Efficacy of fluoro-2-deoxy-D-glucose positron emission tomography to evaluate responses to concurrent chemoradiotherapy for head and neck squamous cell carcinoma.
Mori M, Tsukuda M, Horiuchi C, Matsuda H, Taguchi T, Takahashi M, Nishimura G, Komatsu M, Niho T, Sakuma N, Shibata K, Sugisaki S. Mori M, et al. Among authors: sakuma n. Auris Nasus Larynx. 2011 Dec;38(6):724-9. doi: 10.1016/j.anl.2011.04.013. Epub 2011 Jun 12. Auris Nasus Larynx. 2011. PMID: 21665394
Treatment results and prognostic factors for advanced squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy.
Taguchi T, Nishimura G, Takahashi M, Komatsu M, Sano D, Sakuma N, Arai Y, Yamashita Y, Shiono O, Hirama M, Sakuma Y, Ishitoya J, Hata M, Ogino I, Oridate N. Taguchi T, et al. Among authors: sakuma n, sakuma y. Cancer Chemother Pharmacol. 2013 Oct;72(4):837-43. doi: 10.1007/s00280-013-2261-3. Cancer Chemother Pharmacol. 2013. PMID: 23959463
Concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck.
Komatsu M, Shiono O, Taguchi T, Sakuma Y, Nishimura G, Sano D, Sakuma N, Yabuki K, Arai Y, Takahashi M, Isitoya J, Oridate N. Komatsu M, et al. Among authors: sakuma n, sakuma y. Jpn J Clin Oncol. 2014 May;44(5):416-21. doi: 10.1093/jjco/hyu026. Epub 2014 Mar 30. Jpn J Clin Oncol. 2014. PMID: 24688084
[A case report: a repeated cerebrospinal fluid otorrhea].
Arai Y, Sakuma N, Sano D, Takahashi M, Matsuda H, Ikoma R, Sakane S, Niwa K, Cho I, Ishitoya J. Arai Y, et al. Among authors: sakuma n. Nihon Jibiinkoka Gakkai Kaiho. 2013 Mar;116(3):161-4. doi: 10.3950/jibiinkoka.116.161. Nihon Jibiinkoka Gakkai Kaiho. 2013. PMID: 23678672 Japanese.
Postoperative Bio-Chemoradiotherapy Using Cetuximab and Docetaxel in Patients With Cis-Platinum-Intolerant Core High-Risk Head and Neck Cancer: Protocol of a Phase 2 Nonrandomized Clinical Trial.
Nishimura G, Hatakeyama H, Shiono O, Taguri M, Komatsu M, Sano D, Sakuma N, Yabuki K, Arai Y, Shibata K, Chiba Y, Tanabe T, Oridate N. Nishimura G, et al. Among authors: sakuma n. JMIR Res Protoc. 2018 Aug 23;7(8):e11003. doi: 10.2196/11003. JMIR Res Protoc. 2018. PMID: 30139721 Free PMC article.
186 results